Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Metastatic signet-ring cell carcinoma of the urinary bladder: A novel management approach to a rare tumour.

Literature DB >> 26085880

Metastatic signet-ring cell carcinoma of the urinary bladder: A novel management approach to a rare tumour.

Neil Pugashetti¹, Stanley A Yap¹, Primo N Lara², Regina Gandour-Edwards³, Marc A Dall'Era¹.

Abstract

Primary signet-ring cell carcinoma (SRCC) of the urinary bladder, a variant of adenocarcinoma, is exceedingly rare and as a result no gold standard exists for its management. We report a case of primary SRCC of the bladder with recurrent metastases; we utilized an innovative diagnostic approach and the patient exhibited a treatment response to palliative FOLFOX-6 chemotherapy.

Entities: Disease Species

Year: 2015 PMID： 26085880 PMCID： PMC4455640 DOI： 10.5489/cuaj.2447

Source DB: PubMed Journal: Can Urol Assoc J ISSN： 1911-6470 Impact factor: 1.862

14 in total

1. p63, CK7, PAX8 and INI-1: an optimal immunohistochemical panel to distinguish poorly differentiated urothelial cell carcinoma from high-grade tumours of the renal collecting system.

Authors: Jason C Carvalho; Dafydd G Thomas; Jonathan B McHugh; Rajal B Shah; Lakshmi P Kunju
Journal: Histopathology Date: 2012-01-19 Impact factor: 5.087

2. Sustained response of adenocarcinoma of the urinary bladder to FOLFOX plus bevacizumab.

Authors: Minyuen Teo; Niall C Swan; Ray S McDermott
Journal: Nat Rev Urol Date: 2011-04-12 Impact factor: 14.432

3. Metastatic signet-ring cell cancer of the bladder responding to chemotherapy with capecitabine: case report and review of literature.

Authors: Jorg Michels; Sean Barbour; Douglas Cavers; Kim N Chi
Journal: Can Urol Assoc J Date: 2010-04 Impact factor: 1.862

4. Primary signet ring cell carcinoma of the bladder: a report on 10 cases.

Authors: S Holmäng; G Borghede; S L Johansson
Journal: Scand J Urol Nephrol Date: 1997-04

5. Primary adenocarcinoma of the urinary bladder. A clinicopathologic analysis of 72 cases.

Authors: D J Grignon; J Y Ro; A G Ayala; D E Johnson; N G Ordóñez
Journal: Cancer Date: 1991-04-15 Impact factor: 6.860

6. FOLFIRI followed by FOLFOX6 or the reverse sequence in advanced colorectal cancer: a randomized GERCOR study.

Authors: Christophe Tournigand; Thierry André; Emmanuel Achille; Gérard Lledo; Michel Flesh; Dominique Mery-Mignard; Emmanuel Quinaux; Corinne Couteau; Marc Buyse; Gérard Ganem; Bruno Landi; Philippe Colin; Christophe Louvet; Aimery de Gramont
Journal: J Clin Oncol Date: 2003-12-02 Impact factor: 44.544

7. Clinicopathologic features and utility of immunohistochemical markers in signet-ring cell adenocarcinoma of the bladder.

Authors: Anil A Thomas; Andrew J Stephenson; Steven C Campbell; J Stephen Jones; Donna E Hansel
Journal: Hum Pathol Date: 2008-09-11 Impact factor: 3.466

Metastatic signet-ring cell carcinoma of the urinary bladder: A novel management approach to a rare tumour.

1. p63, CK7, PAX8 and INI-1: an optimal immunohistochemical panel to distinguish poorly differentiated urothelial cell carcinoma from high-grade tumours of the renal collecting system.

2. Sustained response of adenocarcinoma of the urinary bladder to FOLFOX plus bevacizumab.

3. Metastatic signet-ring cell cancer of the bladder responding to chemotherapy with capecitabine: case report and review of literature.

4. Primary signet ring cell carcinoma of the bladder: a report on 10 cases.

5. Primary adenocarcinoma of the urinary bladder. A clinicopathologic analysis of 72 cases.

6. FOLFIRI followed by FOLFOX6 or the reverse sequence in advanced colorectal cancer: a randomized GERCOR study.

7. Clinicopathologic features and utility of immunohistochemical markers in signet-ring cell adenocarcinoma of the bladder.

Review 8. Signet-ring cell adenocarcinoma of bladder.

Review 9. Primary signet-ring cell carcinoma of the urinary bladder.

Review 10. Malignant non-urothelial neoplasms of the urinary bladder: a review.

1. Primary signet-ring cell carcinoma of the urinary bladder.

2. Surgery improves survival in bladder signet-ring cell carcinoma-a population-based study.

3. Clinicopathological Characteristics and Prognostic Factors of Primary Bladder Signet Ring Cell Carcinoma.